Determination of the arpromidine-type histamine H2-receptor agonist N1-[3-(3,4-difluorophenyl)-3-2-pyridyl)propyl]-N2-[3-(1H-imidazol-4 -yl)propyl]guanidine and corresponding N3-alkoxycarbonylguanidines by HPLC and CE

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 2, 1997, Pages 79-88

  Schuster, A ^a   Bernhardt, G ^a   Buschauer, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Alkoxycarbonylguanidines; Arpromidine analogues; Capillary zone electrophoresis; Guanidines; Histamine H2 receptor agonists; HPLC

Indexed keywords

ARPROMIDINE; GUANIDINE DERIVATIVE; HISTAMINE H2 RECEPTOR AGONIST; PRODRUG;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

EID: 0030944316     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(96)00258-8     Document Type: Article

References (17)

1. 2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure. Pharmacol. Ther. 24, 165-177.
2. Buschauer, A. (1989) Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. J. Med. Chem. 32, 1963-1970.
3. 2 agonists. Arch. Pharm. (Weinheim) 326, 665 (1993).
4. Conn, R.B. and Davis, R.B. (1959) Green fluorescence of guanidinium compounds with ninhydrin. Nature (London) 183, 1053-1055.
5. 2-receptors. Nature (London) 276, 403-405.
6. Engelhardt, H., Beck, W. and Schmitt, T. (1994) Kapillarelektrophorese: Methoden und Möglichkeiten. Vieweg Verlag, Braunschweig, Wiesbaden.
7. 2-receptor agonists in congestive heart failure. Eur. J. Clin Invest. 25, 42-46.
8. Hirage, Y. and Kinoshita, T. (1981) Post-column derivatization of guanidino compounds in high-performance liquid chromatography using ninhydrin. J. Chromatogr. 226, 43-51.
9. 2 agonist arpromidine: role of the guanidine group. Bioorg. Med. Chem. Lett. 5, 2065-2070.
10. Kuhn, R. and Hoffstetter-Kuhn, S. (1993) Capillary Electrophoresis: Principles and Practice. Springer Verlag, Berlin.
11. Michel, M.C. and Motulsky, H.J. (1990) He 90481: a competitive nonpeptidergic antagonist at neuropeptide Y receptors. Ann. NY Acad. Sci. 611, 392-394.
12. 3-(alkoxycarbonyl)guanidines and analogs as cardiotonics. S. African Pat. ZA 88 01,271 (cf. Eur. Pat. Appl. EP 0 302 164); Chem. Abstr. 111, 134154x (1989).
13. Mörsdorf, P., Engler, H., Schickaneder, H. and Ahrens, K.H. (1991) Preparation of N′-[3-(3,4-difluorophenyl)-3-(2-pyridyl)propyl]-N′-tert- butoxycarbonyl-N-[3-(1H-imidazol-4-yl)propyl]guanidine as a cardiovascular drug. Eur. Pat. Appl. EP 437,645. Chem. Abstr. 115, 183303m (1991).
14. 2-agonists. Drugs Fut. 15, 919-933.
15. Pfeifer, S., Pflegel, P. and Borchert, H.H. (1995) Biopharmazie. Pharmakokinetik - Bioverfügbarkeit - Biotransformation. 3rd. edn. Ullstein Mosby GmbH and KG, Berlin, Wiesbaden, pp. 65-69.
16. 1-antagonism in rat endotoxic shock. Shock 2, 47-52.
17. Yamada, S. and Itano, H.A. (1966) Phenanthrenequinone as an analytical reagent for arginine and other monosubstituted guanidines. Biochim. Biophys. Acta 130, 538-540.